Haemonetics Corporation (HAE)
Debt-to-capital ratio
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 820,836 | 959,959 | 817,997 | 749,424 | 731,670 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $820,836K)
= 0.00
The debt-to-capital ratio for Haemonetics Corporation has been consistently at 0.00 from March 31, 2021, to March 31, 2024. However, for March 31, 2025, the ratio is reported as "—", indicating a lack of available data for that period. A debt-to-capital ratio of 0.00 typically suggests that the company is not using any debt to finance its operations and investments, and instead relies on equity financing. This may indicate a conservative financial strategy, lower financial risk, and better financial health as the company is not highly leveraged.
Peer comparison
Mar 31, 2025